ANSYS Announces Exceptional Q3 Results, With Double-Digit Growth in Revenue, EPS, ACV and Operating Cash Flow
Company Increases FY 2018 Guidance for Revenue (ASC 606), EPS and Operating Cash Flow ASC 606 – Third Quarter 2018 […]
ANSYS Announces Exceptional Q3 Results, With Double-Digit Growth in Revenue, EPS, ACV and Operating Cash Flow
Company Increases FY 2018 Guidance for Revenue (ASC 606), EPS and Operating Cash Flow ASC 606 – Third Quarter 2018 […]
Tribune Publishing Reports Third Quarter 2018 Results
CHICAGO, Nov. 07, 2018 (GLOBE NEWSWIRE) — Tribune Publishing Company (NASDAQ:TPCO) today announced financial results for the third quarter ended […]
Tribune Publishing Reports Third Quarter 2018 Results
CHICAGO, Nov. 07, 2018 (GLOBE NEWSWIRE) — Tribune Publishing Company (NASDAQ:TPCO) today announced financial results for the third quarter ended […]
Flushing Bank Investment Grade Ratings Affirmed by Kroll Bond Rating Agency, Inc.
UNIONDALE, N.Y., Nov. 07, 2018 (GLOBE NEWSWIRE) — Flushing Financial Corporation (the “Company”) (Nasdaq-GS: FFIC), the parent holding company for […]
Flushing Bank Investment Grade Ratings Affirmed by Kroll Bond Rating Agency, Inc.
UNIONDALE, N.Y., Nov. 07, 2018 (GLOBE NEWSWIRE) — Flushing Financial Corporation (the “Company”) (Nasdaq-GS: FFIC), the parent holding company for […]
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results
-Initiated Phase 1/2 Clinical Trial of CTX001 in β-thalassemia- -Targeting Initiation of Clinical Trial for CTX110, Targeting CD19+ Malignancies, in 1H […]
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results
-Initiated Phase 1/2 Clinical Trial of CTX001 in β-thalassemia- -Targeting Initiation of Clinical Trial for CTX110, Targeting CD19+ Malignancies, in 1H […]
Verrica Pharmaceuticals Reports Third Quarter 2018 Financial Results
WEST CHESTER, Pa., Nov. 07, 2018 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a pharmaceutical company focused on […]
Verrica Pharmaceuticals Reports Third Quarter 2018 Financial Results
WEST CHESTER, Pa., Nov. 07, 2018 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a pharmaceutical company focused on […]
